Page last updated: 2024-10-25

clofibric acid and Anterior Circulation Transient Ischemic Attack

clofibric acid has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies

Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.

Research Excerpts

ExcerptRelevanceReference
"Bezafibrate is a new lipid-lowering agent that quite constantly increases low HDL-cholesterol values in hyperlipoproteinaemic patients."1.26Effects of bezafibrate on low HDL-cholesterol in patients with ischaemic cerebrovascular disease: a pilot study. ( Kjellin, KG; Ledermann, H; Noring, L, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mullard, AJ1
Reeves, MJ1
Jacobs, BS1
Kothari, RU1
Birbeck, GL1
Maddox, K1
Stoeckle-Roberts, S1
Wehner, S1
Noring, L1
Kjellin, KG1
Ledermann, H1

Other Studies

2 other studies available for clofibric acid and Anterior Circulation Transient Ischemic Attack

ArticleYear
Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
    Stroke, 2006, Volume: 37, Issue:1

    Topics: Aged; Anticoagulants; Cholestyramine Resin; Clofibric Acid; Female; Hospital Records; Hospitalizatio

2006
Effects of bezafibrate on low HDL-cholesterol in patients with ischaemic cerebrovascular disease: a pilot study.
    The Journal of international medical research, 1981, Volume: 9, Issue:5

    Topics: Adult; Bezafibrate; Cerebral Infarction; Cholesterol; Cholesterol, HDL; Clofibrate; Clofibric Acid;

1981